Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Alentis Therapeutics AG
Merck Sharp & Dohme LLC
Neonc Technologies, Inc.
Terremoto Biosciences Inc.
Merus B.V.
Servier
Merck Sharp & Dohme LLC
Radiopharm Theranostics, Ltd
DualityBio Inc.
Yuhan Corporation
Rapa Therapeutics LLC
AP Biosciences Inc.
Jacobio Pharmaceuticals Co., Ltd.
Sunshine Lake Pharma Co., Ltd.
Sinocelltech Ltd.